06/05/2026
Last month, we welcomed Kiomedine-vs‑one into the Hospital Innovations portfolio.
Kiomedine-vs‑one brings a new approach to knee osteoarthritis care.
This single‑injection fluid implant is designed to support symptomatic management, using a world‑first animal‑free CM‑Chitosan derived from sustainably sourced button mushrooms. Its dual‑action concept focuses on joint lubrication and reducing oxidative stress.
Kiomedine-vs-one is expanding what’s possible in knee OA management.
Contact us to find out more! 🍄🟫